Clinical pharmacology and therapeutic use of hyaluronidase with special consideration to hylase 'Dessau';KLINISCHE PHARMAKOLOGIE UND ANWENDUNGSMOGLICHKEITEN VON HYALURONIDASE UNTER BERUCKSICHTIGUNG VON HYLASE 'DESSAU'

Wiener Medizinische Wochenschrift

Volumn 147, Issue 15, 1997, Pages 347-355

  Farr, C ^a,e   Menzel, J ^b   Seeberger, J ^c   Schweigle, B ^d  

^a Firma Faromed   (Austria)

^b UNIVERSITY OF VIENNA   (Austria)

^c Praxis für Allgemeinmedizin   (Austria)

^d Firma Pharma Dessau   (Germany)

^e Faromed   (Austria)

Author keywords

Clinical pharmacology; Dermatology; Hyaluronidase; Myocard infarction; Oncology; Orthopaedia; Peri and retrobulbar anesthesia

Indexed keywords

HYALURONIDASE; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE;

ARTICLE; CLINICAL PHARMACOLOGY; DERMATOLOGY; GYNECOLOGY; INTERNAL MEDICINE; INTRAMUSCULAR DRUG ADMINISTRATION; LOCAL ANESTHESIA; MEMBRANE PERMEABILITY; NONHUMAN; ONCOLOGY; ORTHOPEDICS; RETROBULBAR ANESTHESIA; VISCOSITY; ABSORPTION; CELL MEMBRANE PERMEABILITY; DRUG EFFECT; HUMAN; METABOLISM; REVIEW; SUBCUTANEOUS DRUG ADMINISTRATION;

ABSORPTION; ANESTHESIA, LOCAL; CELL MEMBRANE PERMEABILITY; HUMANS; HYALURONIC ACID; HYALURONOGLUCOSAMINIDASE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS;

EID: 0030821736     PISSN: 00435341     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. Abelson MB, Mandel E: The effect of hyaluronidase on akinesia during cataract surgery. Ophthalm Surg 1989;20:325-326.
2. Adamian LV, Mynbaev OA, Strugatskii VM: (An experimental validation of hyaluronidase electrophoresis for the prevention of postoperative adhesions). Vopr Kurortol Fizioter Lech Fiz Kult 1995;3:18-20.
3. Atkinson WS: Use of hyaluronidase with local anesthesia in ophthalmology: preliminary report. Arch Ophthalmol 1949;42:628-633.
4. Bartolucci C, Cellai L, Corradini C, Lamba D, Velona I: Chondroproective action of chondroitin sulfate. Competetive action of chondroitin sulfate on the digestion of hyaluronan by bovine testicular hyaluronidase. Int J Tiss React 1991;13:311-317.
5. Baumgartner G: Hyaluronidase in der Therapie maligner Erkrankungen. Wien klin Wschr 1987;99 (suppl 174): 1-22.
6. Baumgartner G, Horaczek A, Grunert P, Kitz K, Wunsch M: Hyaluronidase als Zusatz zur zytostalischen Chemotherapie bei Glioblastomen. Onkologie 1987;10:100-103.
7. Baumgartner G, Horaezek A, Kluza HP, Maier U, Moritz A, Neumann H, Partsch H, Zänker KS: Hyaluronidase: Anwendung in der Onkologie - Übersicht über experimentelle und klinische Daten. Hyaluronidase. Wien. Springer. 1988, pp 1-79.
8. Beckenlehner K, Bannke S, Spruss T, Bernhardt G, Schönenberger H, Sehiess W: Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo. J Cancer Res Clin Oncol 1992;118:591-596.
9. Bellmann H, Zacharias J, Böhland W: Anwendung von Hyaluronidase bei Paratenonitis crepitans und Tendinosen (Epicondylitis humeri und Periarthritis humeroscapularis). Z ärztl Fortb 1970;64/H8:385-390.
10. Bellmann H, Rauchfuss E, Böhland W, Scheuner G, Hutschenreiter J, Brand G, Sandner K: Zur pharmakodynamischen Wirkung der kombinierten Anwendung von Hylase "Dessau" und Myocuran in der ambulanten Chirurgie. Z ärztl Forth 1975;69:198-204.
11. Bertelli G, Dini D, Forno GB, Gozza A, Silvestro S, Venturini M, Rosso R, Pronzato P: Hyaluronidase as an antidote to extravasation of Vinca alkaloids: clinical results. J Cancer Res Clin Oncol 1994;120:505-506.
12. Borle RM, Borle SR: Management of oral submucous fibrosis: a conservative approach. J Oral Maxillofac Surg 1991;49:788-791.
13. Breu W: Hyaluronidase (Sammelreferal). Wien klin Wschr 1952;64:435-437.
14. Brown DR, Pacheco EM, Repka MX: Recovery of extraocular muscle function after adjustable suture strabismus surgery under local anesthesia. J Ped Ophthalmol Strab 1992;29:16-20.
15. Brydon CW, Basler M, Kerr WJ: An evaluation of two concentrations of hyaluronidase for supplementation of peribulbar anaesthesia. Anaesthesia 1995;50:998-1000.
16. Calder IG, Smith VH: Hyaluronidase and sodium hyaluronate in cataract surgery. Br J Ophthalmol 1986;70:418-420.
17. Campbell CA, Przyklenk K, Kloner RA: Infaret size reduction: a review of the clinical trials. J Clin Pharmacol 1986;26:317-329.
18. Cerwenka W: Die intravenöse Anwendung von Hylase "Dessau" in der orthopädischen Ambulanz. Medicamentum 1977;18:49.
19. Chain, Duttle (1969). zitiert in: Rapoport SM: Medizinische Biochemie. 5. Aufl. Berlin. Verlag Volk und Gesundheit, 1969. p 698.
20. Clark LE, Mellette JR jr: The Use of Hyaluronidase as an Adjunct to Surgical Procedures. J Dermatol Surg Oncol 1994;20:842-844.
21. Couriss EH, Ransil BJ, Russo J: The effects of hyaluronidase on local anesthesia: a prospective, randomized, controlled, double-blind study. Plast Reconstr Surg 1995;85:876-883.
22. Croix BST, Rak JW, Kapitain S, Sheehan C, Graham CH, Kerbel RS: Reversal by Hyaluronidase of Adhesion-Dependent Multicellular Drug Resistant in Mammary Carcinoma Cells. J Nat Cancer Inst 1996;88:1285-1296.
23. Davis PL, O'Connor P: Peribulbar block for cataract surgery: a prospective double-blind study of two lokal anesthetics. Can J Ophthalmol 1989;24:155-158.
24. Dorr RT: Antidotes to vesicant chemotherapy extravasations. Blood Rev 1990;4:41-60.
25. Duran-Reynals F: Exaltation de l'activité du virus vaccinal par les extraits de certains organes. Compt Rend Séances Soc Biol de Ses Filial 1928;99:6-7.
26. Earnshaw JS, Curtis CG, Powell GM, Dodgson KS, Olavesen AH, Gacesa P: The fate of intraveneously administered highly purfied bovine testicular hyaluronidase (hyalosidase) in the rat. Biochem Pharmacol 1985;34:2199-2203.
27. Eckenhoff JE, Kirby CK: The use of hyaluronidase on regional nerve blocks. Anesthesiology 1951;12:27-32.
28. Gillart T, Bazin JE, Deret C, Aigouy L, Schoeffler P, Raynaud C: Effect of injection pressure on the success rate of peribulbar block. Anaesthesia 1996;51:779-782.
29. Godeau G, Robert AM: Action de l'hyaluronidase testiculaire sur les macromolecules de la matrice extracellulaire cutanee. Etude par analyse d'image informatisee. Pathol Biol Paris 1988;36:833-838.
30. Gupta D, Sharma SC: Oral submucous fibrosis - a new treatment regimen. J Oral Maxillofac Surg 1988;46:830-833.
31. Handke, et al, zitiert in Rapoport: Medizinische Biochemie. 5. Aufl. Berlin, Verlag Volk und Gesundheit, 1969, p 698.
32. Hessemer V, Heinrich A, Jacobi KW: Ocular circulatory changes caused by retrobulbar anesthesia with and without added adrenaline. Klin Monatsbl Augenheilk 1990;197:470-479.
33. Hessemer V, Hoppe O, Jacobi KW: Einfluß von Hyaluronidase auf die okulären Kreislaufveränderungen durch Retrobulbäranästhesie. Fortschr Ophthalmol 1991;88:196-200.
34. Hessemer V: Peribulbar anesthesia versus retrobulbar anesthesia with facial nerve block. Techniques, local anesthetics and additives, akinesia and sensory block, complications. Klin Monatsbl Augenheilk 1994;204:75-89.
35. Julian DG, Simpson JM, Cadigan PJ, Petri MC, Hall RJ, Smith RH, Pentecost BL: A controlled trial of GL enzyme in the treatment of acute myocardial infarction. Cardiology 1988;75:177-183.
36. Keeler JF, Simpson KH, Ellis FR, Kay SP: Effect of addition of hyaluronidase to bupivacaine during axillary brachial plexus block. Br J Anaesthesia 1992;68:68-71.
37. Kirby CK, Eckenhoff JE, Looby JP: The use of hyaluronidase with local anesthetic agents in surgery and dentistry. Ann N Y Acad Sci 1950;52:1166-1170.
38. Klocker J, Sabitzer H, Raunik W, Wieser S, Schumer J: Combined application of cisplatin. vindesine, hyaluronidase and radiation for treatment of advanced squamous cell carcinoma of the head and neck. Am J Clin Oncol 1995;18:425-428.
39. Kohno N, Ichikawa-Kawasaki K, Kawaida M, Ohnuma T: (Combination chemotherapy of solid tumor-effects of hyaluronidase on doxorubicin [DXR] penetration into multicellular tumor spheroids [MTS]). Gan To Kagaku Ryoho 1992;19:981-986.
40. Kohno N, Ohnuma T, Truog P: Effects of hyaluronidase on doxorubicin penetration into squamous carcinoma multicellular tumor spheroids and its cell lethality. J Cancer Res Clin Oncol 1994;120:293-297.
41. Kretschmar KH: Anwendung von Hylase bei akuter Tendovaginitis crepitans. Dtsch Gesundheitswesen 1968;23:696-698.
42. Kretschmar KH, Bellmann H, Fetter O, Senitz D, Zacharias J, Kretschmar K: Klinische Erfahrungen und experimentelle Befunde bei hochdosierter intravenöser Verabfolgung von Hylase "Dessau". Dtsch Gesundheitswesen 1972;27:1608-1612.
43. Krohn J, Seland JH, Hovding G, Bertelsen T, Aasved H, Haugen OH: Retrobulbar anesthesia with and without hyaluronidase in extra-capsular cataract surgery. A prospective, randomized, double-blind study. Acta Ophthalmol Copenh 1993;71:791-795.
44. Krohn J, Hovding G, Seland JH, Aasved H: Retrobulbar anesthesia with and without adrena-line in extracapsular cataract surgery. A prospective, randomized, double-blind study. Acta Ophthalmol Scand 1995;73:56-60.
45. Lai DR, Chen HR, Lin LM, Huang YL, Tsai CC: Clinical evaluation of different treatment methods for oral submucous fibrosis. A 10-year experience with 150 cases. J Oral Pathol Med 1995;24:402-406.
46. Landsman L, Mandy SH: Adjuncts to scalp reduction surgery. Intraoperative tissue expanders and hyaluronidase. J Dermatol Surg Oncol 1991;17:670-672.
47. Lange W, Denffer Hv, Honis M: Comparison of the effect of 0.75% bupivacaine with 0.75% bupivacaine / 2% mepivacaine in retrobulbar anesthesia and the effect of adding hyaluronidase. Fortschr Ophthalmol 1989;86:312-315.
48. Laurent UGB, Tenglad A: Determination of hyaluronate in biological samples by a specific radioassay technique. Ann Biochem 1980;109:386-394.
49. Martins de Oliviera J, Carballo R, Zimmerman HA: Intravenous injection of hyaluronidase in acute myocardial infarction: Preliminary report of clinical and experimental observations. Am Heart J 1959;57:712-722.
50. Meyer K: Hyaluronidases. In Boyer PD (ed): The Enzymes. Vol 5. New York-London, 1971. pp 307-320.
51. MILIS Study Group: Hyaluronidase therapy for acute myocardial infarction: results of a randomized, blinded, multicenter trial. Am J Cardiol 1986;57:1236-1243.
52. Moore DC: An evaluation of hyaluronidase in local and nerve block analgesia: A review of 519 cases. Anesthesiology 1950;11:470-484.
53. Nathan N, Benrhaiem M, Lotfi H, Debord J, Rigaud G, Lachatre G, Adenis JP, Feiss P: The role of hyaluronidase on lidocaine and bupi-vacaine pharmacokinetics after peribulbar blockade. Anesth Analg 1996;82:1060-1064.
54. Nicoll JMV, Treuren B, Acarya PA, Ahlen K, James M: Retrobulbar Anaesthesia: The role of hyaluronidase. Anesth Analg 1986;65:1324-1328.
55. Nitzschner H: Verlaufsbeobachtungen der Sklerodermie nach kombinierter Hylase-Carnitin-Therapie. Z ärztl Fortb 1975;69:1108.
56. Pasaoglu A, Yildizhan A, Kandemir B: Treatment of experimental brain abscess. 2. Effects of combinations of hyaluronidase with antibiotics and dexamethasone. Acta Neurochir Wien 1989;100:79-83.
57. Patel BC, Burns TA, Crandall A, Shomaker ST, Pace NL, Van Eerd A, Clinch T: A comparison of topical and retrobulbar anesthesia for cataract surgery. Ophthalmology 1996;103:1196-1203.
58. Payne JW, Rupp NH: The use of hyaluronidase in caudal block anesthesia. Anesthesiology 1951;12:164-172.
59. Petter O, Bellmann H: Theoretische Aspekte zu neuen Anwendungsmöglichkeiten der Hyaluronidase. Z Inn Med 1971;26:171-174.
60. Petzold E, Karschunke HJ, Richter W: Der Einfluß von intraartikulär applizierter Hylase "Dessau" auf die chemisch induzierte Gonarthrose der Ratte. Beitr Orthop Traumatol 1987;34:333-342.
61. Rankova CB, Siarov NP, Petkova N: Application of hyaluronidase after unsuccessful trabeculectomy. Doc Ophthalmol 1992;80:381-383.
62. Robert AM, Godeau G: Action of protcolytic and glycolytic enzymes on the permeability of the blood-brain barrier. Biomedicine 1974;21:36-39.
63. Ruusuvaara P, Pajari S, Setälä K: Effect of sodium hyaluronate on immediate postoperative intraocular pressure after extracapsular cataract extraction and IOL implantation. Acta Ophthal 1990;68:721-727.
64. Sanders AB: Myocardial salvage: pharmacologic treatment. Emerg Med Clin North Am 1988;6:261-372.
65. Sanders RJ, Nelson LB, Deutsch JA: Peribulbar anesthesia for strabismus surgery. Am J Ophthalmol 1990;109:705-708.
66. Scott DB: Hyaluronidase in epidural analgesia. Br J Analgesia 1956;28:187-193.
67. Seifter J: Studies on the pharmacology and toxicology of testicular hyaluronidase. Ann N Y Acad Sci 1950;52:1141-1155.
68. Thomson I: Addition of hyaluronidase to lignocaine with adrenaline for retrobulbar anaesthesia in the surgery of senile cataract. Br J Ophthalmol 1988;72:700-702.
69. Ursell PG, Spalton DJ: The effect of solution temperature on the pain of peribulbar anesthesia. Ophthalmology 1996;103:839-841.
70. Watson D: Hyaluronidase. Br J Anaesth 1993;71:422-425.
71. Wolf RA, Chaung LY, O'Hara D, Smith TW, Muller JE: The Serum Kinetics of Bovine Testicular Hyaluronidase in Dogs. Rats and Humans. J Pharm Exper Ther 1982;222:331-337.
72. Wood G, Simpson T: The effect of hyaluronidase on the speed of onset of retrobulbar anaesthesia. Can J Anaesth 1990;37:62.
73. Wozniak HD, Braun W: Erste Erfahrungen mit hochdosierter Hyaluronidase-Langzeittherapie [Hylase "Dessau"] in der Dermatologie. Dtsch Gesundheitswesen 1972;27:221-223.
74. Wozniak KD, Braun W: Zur Behandlung mit Hyaluronidasu in der Dermatologie. Z ärztl Fortb 1975;69:1109-1110.
75. Yusuf S: Interventions that potentially limit myocardial infart size: overview of clinical trials. Am J Cardiol 1987;60:11A-17A.
76. Yusuf S: An overview of the clinical trials of agents (other than betablockers) that potentially limit myocardial infarct size. J Cardiovasc Pharmacol 1988;12 (suppl 1): 48-55.
77. Zehetmayer M, Radax U, Skorpik C, Menapace R, Schemper M, Weghaupt H, Scholz U: Topical versus peribulbar anesthesia In clear corneal cataract surgery. J Cataract Refract Surg 1996;22:480-484.